Efficacy, Safety and Tolerability of a Novel High-Purity, Double Virus-Inactivated VWF/FVIII-Concentrate in the Treatment of Von Willebrand Disease (VWD) - Clinical Experience in the Treatment of Bleeding and Surgery.
- Resource Type
- Abstract
- Source
- In
Blood 16 November 2007 110(11):2144-2144 - Subject
- Language
- ISSN
- 0006-4971